1st Quarter - Report

NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION for NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION

Firm
Client
Income
—
Expenses
$565,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Energy/Nuclear ENG

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competition in the global marketplace

LobbyistCovered position, as disclosed
MADELEINE BUGEL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1260 (117th), H.R. 4521 (117th)

Environment/Superfund ENV

Preparation for and meeting with EPA officials on the Toxic Substances Control Act

LobbyistCovered position, as disclosed
LAURA SREBNIK —

Contacted: Environmental Protection Agency (EPA)

Health Issues HCR

Advocacy on PDUFA and GDUFA user fee legislation/regulation seeking to maintain certain exemptions for positron emission tomography imaging drugs Advocacy on H.R. 7253, the Clarifying Remanufacturing to Protect Patient Safety Act, seeking clarification the definition of remanufacturing, education and inspections; advocacy on cybersecurity vulnerabilities of legacy medical imaging devices; advocacy on artificial intelligence and need for reimbursement pathway; advocacy on focused ultrasound and need for improved coverage pathways and research funding; advocacy on medical device user fees

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
HOLLY GROSHOLZ —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7253 (117th)

Labor Issues/Antitrust/Workplace LBR

Raising awareness to Congress regarding potential negative-job impact of DOE rule on GSL backstop implementation

LobbyistCovered position, as disclosed
PETER FERRELL —

Contacted: HOUSE OF REPRESENTATIVES

Manufacturing MAN

Support Buy American guidance for Infrastructure Investment and Jobs Act (IIJA) implementation that will allow electroindustry companies to qualify for federal assistance from the IIJA

LobbyistCovered position, as disclosed
MADELEINE BUGEL —

Contacted: White House Office

Medicare/Medicaid MMM

Advocacy on HR 4479/S 2609, The FIND Act, seeking separate reimbursement for radiopharmaceuticals in the Medicare hospital outpatient setting. Advocacy on the CMS Final Decision regarding appropriate coverage for Monoclonal Antibody therapies and PET diagnostics.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4479 (117th)

Science/Technology SCI

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competition in the global marketplace

LobbyistCovered position, as disclosed
MADELEINE BUGEL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1260 (117th), H.R. 4521 (117th)

Tariff (miscellaneous tariff bills) TAR

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competiveness in the global marketplace

LobbyistCovered position, as disclosed
MADELEINE BUGEL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1260 (117th), H.R. 4521 (117th)

Trade (domestic/foreign) TRD

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competiveness in the global marketplace

LobbyistCovered position, as disclosed
MADELEINE BUGEL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4521 (117th), S. 1260 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.